UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000009430
Receipt No. R000011081
Scientific Title The double-blind, randomised controlled phase II study of the adjuvant therapy using alpha-galactosylceramide pulsed antigen presenting cells for patients with head and neck mucosal melanoma followed by a carbon ion radiotherapy.
Date of disclosure of the study information 2012/11/29
Last modified on 2019/01/28 20:41:10

No. Disposal Last modified on Item of update
1 Insert 2012/11/29 14:24:12
2 Update 2012/11/29 15:14:49 Key exclusion criteria
Key exclusion criteria
3 Update 2012/11/29 15:26:48 Key exclusion criteria
4 Update 2012/11/29 15:45:09 Address
5 Update 2012/12/21 14:36:54 Public title
6 Update 2012/12/21 14:39:16 Acronym
7 Update 2012/12/21 14:41:14 Condition
8 Update 2012/12/21 15:14:07 Narrative objectives1
Key secondary outcomes
9 Update 2012/12/21 15:29:37 Interventions/Control_1
Interventions/Control_2
Key inclusion criteria
10 Update 2012/12/21 15:31:40 UMIN ID1
11 Update 2019/01/28 20:41:10 Recruitment status


Contact us.